Facebook Pixel

HIV Drug Combination Poses Heart Risk: FDA

Rate This
AIDS / HIV related image

Two anti-HIV drugs pose potential heart risks when used together, the U.S. Food and Drug Administration warned Tuesday.

Taken in combination, Abbott Laboratories' Norvir and a Roche medication, Invirase, can alter electrical activity of the heart, according to preliminary data reviewed by the FDA, the Associated Press reported.

The result may be irregular heart rhythms that can trigger fainting and even death.

Invirase was approved 15 years ago, the AP said. It is prescribed with Norvir and other anti-viral drugs to control HIV, the virus that causes AIDS, in adults.

The FDA said its information comes from data submitted by Roche and noted its review is continuing.

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy



Get Email Updates

AIDS / HIV Guide

Have a question? We're here to help. Ask the Community.


Health Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER - for free!